Drug Shortage Report for OPTIRAY 320 (ULTRAJECT)
| Report ID | 97485 |
| Drug Identification Number | 02035626 |
| Brand name | OPTIRAY 320 (ULTRAJECT) |
| Common or Proper name | Ioversol Injection 68% |
| Company Name | LIEBEL-FLARSHEIM COMPANY LLC |
| Market Status | MARKETED |
| Active Ingredient(s) | IOVERSOL |
| Strength(s) | 68% |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVASCULAR |
| Packaging size | 125 ml |
| ATC code | V08AB |
| ATC description | X-RAY CONTRAST MEDIA, IODINATED |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-10-30 |
| Estimated end date | 2020-01-30 |
| Actual end date | 2020-01-17 |
| Shortage status | Resolved |
| Updated date | 2020-02-05 |
| Company comments | For more information, please contact Methapharm Inc. at 1-800-287-7686, sales@methapharm.com. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 8800 DURANT RD. RALEIGH, NORTH CAROLINA UNITED STATES 27616 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2020-02-05 | French | Compare |
| v5 | 2020-02-05 | English | Compare |
| v4 | 2019-10-31 | English | Compare |
| v3 | 2019-10-30 | French | Compare |
| v2 | 2019-10-30 | English | Compare |
| v1 | 2019-10-30 | English | Compare |
Showing 1 to 6 of 6